![]() |
|
|
Vol. 303, Issue 2, 880-887, November 2002
Faculty of Pharmaceutical Sciences, Kumamoto University, Kumamoto,
Japan (Y.T., T.D., M.O.); Institute of Pharmaceutical Sciences,
Hiroshima University School of Medicine, Hiroshima, Japan (M.T.);
Daiichi College of Pharmaceutical Sciences, Fukuoka, Japan (A.T.); and
Department of Pharmacology and Therapeutics, University of Liverpool,
Liverpool, England (W.E.L.)
The aim of this study was to understand the mechanisms that underlie
the renal elimination of albumin-bound uremic toxins, particularly the
highly bound furan acid 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), that accumulate in chronic renal failure. These toxins inhibit the binding of acidic drugs and have various other untoward effects. The pharmacokinetics and tissue distribution of CMPF plus
three other such toxins, indoxyl sulfate, indole acetic acid, and
hippuric acid, have been examined in the anesthetized rat. The effects
of p-aminohippuric (PAH) acid and tetraethylammonium on
the uptake of CMPF by rat renal cortical slices in vitro were also
investigated to characterize its mechanism of uptake. Plasma and tissue
concentrations of the uremic toxins were determined by high-performance
liquid chromatography. The rate of elimination of the toxins
from plasma was indoxyl sulfate > hippuric acid > indole
acetic acid > CMPF. Although the renal clearance of CMPF was low,
its main elimination pathway was via urinary excretion with active
tubular secretion. In renal cortical slice experiments, mutual
inhibition between CMPF and PAH was observed. In addition,
-ketoglutarate stimulated the uptake of CMPF by renal cortical slices. The base tetraethylammonium did not inhibit slice uptake of
CMPF. The pharmacokinetics of CMPF was characterized by slow plasma
clearance and localization in the kidney. Furthermore, the evidence
from experiments with renal cortical slices indicates that the uptake
of CMPF is mediated by an anion/dicarboxylate exchanger, similar to
that for PAH.
This article has been cited by other articles:
![]() |
O. Kwon, S.-M. Hong, and K. Blouch Alteration in Renal Organic Anion Transporter 1 After Ischemia/Reperfusion in Cadaveric Renal Allografts J. Histochem. Cytochem., June 1, 2007; 55(6): 575 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Deguchi, M. Takemoto, N. Uehara, W. E. Lindup, A. Suenaga, and M. Otagiri Renal Clearance of Endogenous Hippurate Correlates with Expression Levels of Renal Organic Anion Transporters in Uremic Rats J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 932 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun, Y. Huang, L. Frassetto, and L. Z. Benet EFFECTS OF UREMIC TOXINS ON HEPATIC UPTAKE AND METABOLISM OF ERYTHROMYCIN Drug Metab. Dispos., November 1, 2004; 32(11): 1239 - 1246. [Abstract] [Full Text] [PDF] |
||||